Pharmaceutical News

RSS

National Community Pharmacists Association to launch ad campaign to lobby lawmakers for policy changes

The National Community Pharmacists Association this week plans to launch a new advertising campaign that asks lawmakers to address two policies that the group maintains has or will result in closures of community pharmacies, CongressDaily reports. As part of the launch of the campaign, about 500 community pharmacists and independent pharmacy owners will visit Washington, D.C.

19 May 2008

Taiwan approves WTO amendment allowing countries to export lower-cost versions of antiretrovirals, other drugs to developing countries

Taiwan's legislative body the Yuan on Thursday approved the first reading of a proposed World Trade Organization amendment that would allow pharmaceutical companies to make lower-cost versions of generic antiretroviral drugs, as well as drugs for malaria and other diseases, to sell to developing countries, the CNA/Taipei Times reports.

19 May 2008

Spectrum Pharmaceuticals to present data on Ortataxel in breast cancer at major oncology meeting

Spectrum Pharmaceuticals, Inc., will present Phase 2 data on ortataxel at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting being held May 30 to June 3, 2008 at the McCormick Place Convention Center in Chicago, Illinois.

19 May 2008

Nasal gel to fight superbug MRSA

British scientists are well on the way to developing a new drug to fight the 'superbug' Methicillin-resistant Staphylococcus aureus (MRSA).

19 May 2008

First pre-pandemic bird flu vaccine available in Europe

The approval for a licence from the European Commission will place Glaxo ahead of rivals in the vaccine fields and the company says it has already received orders from some governments such as the U.S., Switzerland and Finland.

19 May 2008

Cancer Research UK and AstraZeneca announce innovative deal for promising anti-cancer compound

Cancer Research UK and Cancer Research Technology (CRT) - the charity's development and commercialisation arm - today announced an innovative new arrangement to progress into clinical development a potential anti-cancer compound from AstraZeneca.

19 May 2008

Schering-Plough extends antibody aliance with MorphoSys

MorphoSys AG announced today that Schering-Plough Corporation has decided to extend the current collaboration between the two companies for one year.

19 May 2008

51% of insured U.S. residents regularly take prescription drugs for chronic illnesses

Fifty-one percent of insured U.S. residents last year took one or more prescription drugs for chronic diseases, compared with 50% in the previous four years and 47% in 2001, according to a report released last Tuesday by Medco Health Solutions, the AP/Houston Chronicle reports.

19 May 2008

Aridol authorised for sale in Germany

Pharmaxis Ltd today announced that it has received national approval to market Aridol in Germany.

19 May 2008

New hay fever jab promises year long relief for sufferers

Relief is in sight for millions of hay fever sufferers with the promise of a jab, which lasts for a year, that significantly reduces symptoms.

15 May 2008

Remaining stocks of Trasylol removed

On Nov. 5, 2007, the U.S. Food and Drug Administration announced that Bayer Pharmaceuticals Corp. agreed to an FDA-requested marketing suspension of Trasylol, a drug used to control bleeding during heart surgery. At that time, preliminary results from a Canadian study suggested an increased risk for death compared to two other drugs used to control bleeding.

15 May 2008

GenoMed offers its patented treatment to Chinese earthquake victims

GenoMed has announced that it has offered its treatment to physicians caring for victims of the recent earthquake in China.

14 May 2008

Lawmakers criticize agencies for lack of coordination of prescription drug benefits for federal retirees

A lack of coordination between CMS and the Office of Personnel Management on prescription drug benefits for federal retirees has cost those retirees and the federal government as much as $200 million annually, according to a letter sent to the agencies on Monday by two House Democrats, CQ HealthBeat reports.

13 May 2008

Hawaii Legislature overrides Gov. Lingle's veto of prescription drug importation program

Hawaii lawmakers last week overrode Gov. Linda Lingle's (R) veto of a bill that will enroll the state in I-SaveRx, a program that allows residents to purchase lower-cost prescription drugs from other countries, the AP/Honolulu Advertiser reports.

13 May 2008

Canadian drug company awarded Rwandan contract to provide combination antiretroviral

Rwanda recently accepted a bid from the Toronto-based generic drug company Apotex to supply its fixed-dose combination antiretroviral drug Apo-triAvir to the country, the Toronto Star reports (Toronto Star, 5/9).

13 May 2008

Barr announces approval of generic version of Yasmin (drospirenone and ethinyl estradiol)

Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, Inc., has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) to manufacture and market a generic version of Yasmin (drospirenone and ethinyl estradiol), an oral contraceptive product manufactured and marketed by Bayer Schering Pharma, AG.

9 May 2008

PolyMedix receives clearance to initiate phase I clinical study of novel systemic antibiotic compound

PolyMedix, Inc. has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ("CTA") for its defensin mimetic antibiotic compound, PMX-30063. This notice of no objection allows for the initiation of human clinical studies in Canada. PMX-30063 is the first defensin mimetic antibiotic compound cleared to enter human clinical trials for systemic use, representing an entirely new class of antibiotic drugs.

9 May 2008

FDA approves new formulation of genetically engineered version of Factor VIIa plasma protein

The U.S. Food and Drug Administration today approved a new formulation of the genetically engineered version of Factor VIIa, a plasma protein essential for the clotting of blood. The new formulation allows the product to be stored at room temperature (up to 81 degrees Fahrenheit) for up to two years.

9 May 2008

FDA approves first generic versions of Requip (ropinirole hydrochloride)

The U.S. Food and Drug Administration has approved the first generic versions of Requip (ropinirole hydrochloride) tablets for the treatment of moderate to severe Restless Legs Syndrome.

9 May 2008

New guidelines say botulinum toxin effective for many neurological disorders, but not headache

New guidelines developed by the American Academy of Neurology confirm that the drug botulinum toxin is safe and effective for treating a variety of neurological conditions. Surprisingly, the drug may not be effective for chronic headaches, accrding to Allison Brashear, M.D., professor and chairman of the Department of Neurology at Wake Forest University Baptist Medical Center, who helped develop the guidelines.

9 May 2008

Pharmaceutical News

National Community Pharmacists Association to launch ad campaign to lobby lawmakers for policy changes

Taiwan approves WTO amendment allowing countries to export lower-cost versions of antiretrovirals, other drugs to developing countries

Spectrum Pharmaceuticals to present data on Ortataxel in breast cancer at major oncology meeting

Nasal gel to fight superbug MRSA

First pre-pandemic bird flu vaccine available in Europe

Cancer Research UK and AstraZeneca announce innovative deal for promising anti-cancer compound

Schering-Plough extends antibody aliance with MorphoSys

51% of insured U.S. residents regularly take prescription drugs for chronic illnesses

Aridol authorised for sale in Germany

New hay fever jab promises year long relief for sufferers

Remaining stocks of Trasylol removed

GenoMed offers its patented treatment to Chinese earthquake victims

Lawmakers criticize agencies for lack of coordination of prescription drug benefits for federal retirees

Hawaii Legislature overrides Gov. Lingle's veto of prescription drug importation program

Canadian drug company awarded Rwandan contract to provide combination antiretroviral

Barr announces approval of generic version of Yasmin (drospirenone and ethinyl estradiol)

PolyMedix receives clearance to initiate phase I clinical study of novel systemic antibiotic compound

FDA approves new formulation of genetically engineered version of Factor VIIa plasma protein

FDA approves first generic versions of Requip (ropinirole hydrochloride)

New guidelines say botulinum toxin effective for many neurological disorders, but not headache

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News